EEconomy Read More Irish exports hit record high last year as companies rushed to beat Trump’s tariffs – The Irish Times18 February 2026 The value of Irish exports went up by 16.4 per cent last year to a record €260.3 billion,…
HHealthcare Read More Agentic AI in healthcare: How Life Sciences marketing could achieve $450B in value by 202811 February 2026 Agentic AI in healthcare is graduating from answering prompts to autonomously executing complex marketing tasks – and life…
MMedication Read More Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News9 February 2026 Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints News Roche unveils data behind BTK inhibitor’s phase…
EEU Read More How the EU’s stack of health files was a big win for industry – POLITICO31 December 2025 On Dec. 16 the Commission published its Biotech Act and Safe Hearts Plan, which landed just days after…
HHealthcare Read More China’s new commercial insurance model could broaden access to Alzheimer’s drugs24 December 2025 China’s new commercial insurance formulary looks to expand patient access to Alzheimer’s disease medicines from Eli Lilly and…
MMedication Read More UK lowers new medicine rebate scheme to 14.5% for 2026 – Endpoints News14 December 2025 UK lowers new medicine rebate scheme to 14.5% for 2026 Endpoints News What will be the cost of Keir…
EEU Read More Europe must get its act together to regain global competitiveness, industry says – POLITICO11 December 2025 But there is hope — both for the pharmaceutical industry and beyond. Per Franzén, CEO and managing partner…
EEU Read More Cut deals with Trump – POLITICO3 December 2025 “The pharmaceutical industry in the U.K. has now gained planning security. Such an agreement is still pending for…
HHealthcare Read More Trump admin claims win as UK bows to pressure on NHS drug spending – POLITICO1 December 2025 The NICE threshold will rise to £25,000 to £35,000 for every quality adjusted life year. In return for…
MMedication Read More Ozempic-style drugs should be available to all, not just the rich, says WHO – POLITICO1 December 2025 The WHO wants pharma companies to consider tiered pricing (lower prices in lower-income countries) and voluntary licensing of…